Lymphoma Flashcards
Lymphoma
What percentage paed malignancy
Hodgkin vs NHL
Number nodes
Spread
Extranodal involvement
10% all
Hodgkin
Single node
Orderly spread
Mesenteric & Waldeyer’s ring rarely involved
BM involvement uncommon
Focal liver involvement rather than diffuse
NHL Multiple nodes Random spread Mesenteric nodes & Waldeyers commonly involved Extranodal common
Hodgkin lymphoma % of lymphomas <15y Characterised by \_\_\_\_\_\_ chain lymphadenopathy HSM \_\_\_\_\_ Special cell \_\_\_\_ Three peaks RFs (3)
40% Single chain lymphadenopathy HSM absent Reed Sternberg cell <14y 15-34y 55-75y
EBV
Primary immunodeficiency (eg. AT)
First degree relative
Is Reed Sternberg pathognomic of HL?
HL at risk of what infections
No also seen in NHL and EBV
Probably a monocyte
Viral/fungal/TB infection
30% get VZV
Clinical features of HL
Lymphadenopathy- painless, firm, rubbery
Cervical, supraclavicular, > inguinal axillary
Anterior mediastinal mass in 60%
B sx
- fever for >72h
- drenching night sweats
- Low >10% in 6 mo
Investigations in HL
ESR
Rads
Neutrophilia in 30% Coombs positive haemolysis ESR good marker of disease activity ITP Ferritin Copper
CXR
Cytogenetic markers of Reed Sternberg
CD15, CD30, BLA-36
NHL
Rate of onset
___ chain lymphadenopathy
Extranodal involvement
Cell type in order of commonest
Explosive onset
Multiple chain lymphadenopathy
HSM common
Clonal proliferation of B cells, T cells, indeterminate
NHL
3 histological subtypes
Lymphoblastic
- usually T cell origin
- <25% blasts in BM , extra medullary disease
- overlap with ALL
- mediastinal mass
Small non-cleaved cell lymphoma
- B cell origin
Burkitts (surface Ig positive) or non burkitts
- below diaphragm
T or B cell
- anaplastic large cell
- cutaneous presentation
NHL
Bloods
Special marker
Rads
When is biopsy indicated
Tumour lysis bloods
LDH: tumour burden
CSF
CXR
CT staging
BMA and trephine
Biopsy ASAP: rapid progression
NHL
Rx
Complications of treatment
Which type better prognosis
CHOP
Cyclophosphamide
Hydroxy danorubicin
Vincristine
Prednisone
Very sensitive to steroid
Tumour lysis high risk
B cell slightly better prognosis
NH
Relapse prognosis
Extremely poor prognosis
Occurs early